Pharmaceutical industry

development trend:

  With the quiet coming of 2018, the future health industry will have unprecedented challenges and more exciting development opportunities. The life sciences and healthcare industries will gradually discover these opportunities, and the need to develop strategies and make judgments to reshape health (whether as a healthcare organization, life sciences company, doctor or patient) is growing.

  In addition, the speed and scale of innovation, especially the impact of new science, automation and robotics on future work, has gradually emerged over the years.

The average life expectancy of OECD countries has increased by 5.5 years, from 75 years in 1990 to 80.5 years in 2015.As a result, telemedicine utilization is accelerating, and by 2018, interaction with mobile devices will account for 65% of all interactions, and 80% of doctors have used smartphones and medical applications to provide medical services.

  Global medical payments are expected to increase at a rate of 4.2% per year, from $7.1 trillion in 2015 to $8.7 trillion in 2020. Annual growth in medical technology sales is expected to reach 5.1%, from $369 billion in 2015 to $529.8 billion in 2022.

  In addition, Alzheimer's, obesity, sugar increased in patients with diabetes, leading to a significant increase in the cost of treatment-related diseases. The size of the rare drug market is expected to double by 2022, from $102 billion in 2015 to $209 billion; the precision medical market is expected to expand from $39 billion in 2015 to $87.7 billion in 2023.

solution: